2 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 1 | 1 | Terminated 1 |
Follow Intestinal Failure: new trials by email Literature Review of Intestinal Failure trials Research Report on Intestinal Failure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Functional Sucrase Deficiency in Short Bowel Syndrome Patients With Intestinal Failure Sucrase, Placebo - Short Gut Syndrome | Phase 2 | Terminated | University of Miami | 3 | 2022-01-31 | 2025-10-01 |
| Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure Glucagon-Like Peptide 2, Glucagon like peptide-2 - Intestinal Failure, Short Bowel Syndrome | Phase 1 / Phase 2 | Terminated | Alberta Children's Hospital | 13 | 2012-01-01 | 2014-12-23 |
Short Bowel Syndrome (2) · Enterocolitis, Necrotizing (1) · Gastroschisis (1) · Infant Nutrition Disorders (1) · Intestinal Atresia (1) · Malnutrition (1)
Digestive System Diseases (2) · Gastrointestinal Diseases (2) · Intestinal Diseases (2) · Malabsorption Syndromes (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Postoperative Complications (2) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Abnormalities (1) · Enterocolitis (1) · Gastroenteritis (1) · Hernia (1) · Hernia, Abdominal (1) · Musculoskeletal Abnormalities (1)
Glucagon-Like Peptide 2 (1) · Sucrase (1)
Alberta Children's Hospital (1) · University of Miami (1)
Canada (1) · United States (1)
Amanda Fifi, MD (1) · David Sigalet, MD PhD (1)